3Berner M, Beghetti M, Spahr-Schopfer I,et al. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease.Am J Cardiol, 1996,77:532-535. 被引量：1
4Assreuy J, Cunha FQ, Liew FY, et al. Feedback inhibition of nitric oxide synthase activity by nitric oxide.Br J Pharmacol, 1993,108:833-837. 被引量：1
5Wallis RM, Corbin JD, Francis SH,et al. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.Am J Cardiol,1999,83(suppl 5A):3C-12C. 被引量：1
6Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med, 2002, 165:1098-1102. 被引量：1
7Ghofrani HA, Wiedemann R, Rose F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med, 2002,136:515-522. 被引量：1
8Watanabe H, Ohashi K, Takeuchi K, et al. Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther,2002,71:398-402. 被引量：1
2Ewert P,Schubert S, Peters B, et al. The CP stent-short, long, covered-for the treatment of aortic coarctation,stenosis of pulmonary arteries and caval veins, and Fontan anastomosis in children and adults: an evaluation of 60 stentts in 53 patients [ J ]. Heart,2005,91 (7) :948-953. 被引量：1
